ASHLEY MURPHY: Open Payments
NPI 1831642743 · GRANDVIEW, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$407 in 26 payments from 8 companies in 2025. Trend: 2023 $2,441 · 2024 $567 · 2025 $407
Food & beverage: $407
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 11 | $141 |
| ABBVIE INC. | 5 | $96 |
| Novo Nordisk Inc | 3 | $48 |
| AstraZeneca Pharmaceuticals LP | 2 | $46 |
| GlaxoSmithKline, LLC. | 2 | $29 |
| Lilly USA, LLC | 1 | $17 |
| Merck Sharp & Dohme LLC | 1 | $16 |
| Sumitomo Pharma America, Inc. | 1 | $14 |
Products named: NURTEC ODT, UBRELVY, PREVNAR 20, QULIPTA, Ozempic, BREZTRI, AIRSUPRA, VRAYLAR.
Industry payments across MO — which companies pay providers there.
